Six novel mutations in the fumarylacetoacetate hydrolase gene of patients with hereditary tyrosinemia type I

被引：0
|
作者：
Timmers, C
Grompe, M
机构：
[1] OREGON HLTH SCI UNIV,DEPT MOLEC & MED GENET,PORTLAND,OR 97201
[2] OREGON HLTH SCI UNIV,DEPT PEDIAT,PORTLAND,OR 97201
来源：
HUMAN MUTATION | 1996年 / 7卷 / 04期
关键词：
D O I：
10.1002/(SICI)1098-1004(1996)7:4<367::AID-HUMU14>3.0.CO;2-0
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
[No abstract available]
引用
收藏
页码：367 / 369
页数：3
相关论文
共 50 条
  • [31] MUTATIONS IN FUMARYLACETOACETATE HYDROLASE GENE AND GENOTYPE-PHENOTYPE RELATION
    Ozgul, R. K.
    Guzel, A.
    Mesci, L.
    Sivri, H. S.
    Kilic, M.
    Ozcay, F.
    Gunduz, M.
    Aydin, H., I
    Aliefendioglu, D.
    Coskun, T.
    Dursun, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S22 - S22
  • [32] LABORATORY MONITORING OF PATIENTS WITH HEREDITARY TYROSINEMIA TYPE I
    Schultz, Matthew
    Netzel, Brian
    Singh, Rani
    Gavrilov, Dimitar
    Oglesbee, Devin
    Raymond, Kimiyo
    Rinaldo, Piero
    Tortorelli, Silvia
    Matern, Dietrich
    MOLECULAR GENETICS AND METABOLISM, 2019, 127 (03) : 298 - 299
  • [33] Laboratory monitoring of patients with hereditary tyrosinemia type I
    Schultz, Matthew J.
    Netzel, Brian C.
    Singh, Rani H.
    Pino, Gisele B.
    Gavrilov, Dimitar K.
    Oglesbee, Devin
    Raymond, Kimiyo M.
    Rinaldo, Piero
    Tortorelli, Silvia
    Smith, Wendy E.
    Matern, Dietrich
    MOLECULAR GENETICS AND METABOLISM, 2020, 130 (04) : 247 - 254
  • [34] DEFICIENT FUMARYLACETOACETATE FUMARYLHYDROLASE ACTIVITY IN LYMPHOCYTES AND FIBROBLASTS FROM PATIENTS WITH HEREDITARY TYROSINEMIA
    KVITTINGEN, EA
    HALVORSEN, S
    JELLUM, E
    PEDIATRIC RESEARCH, 1983, 17 (07) : 541 - 544
  • [35] CLONING AND EXPRESSION OF THE CDNA-ENCODING HUMAN FUMARYLACETOACETATE HYDROLASE, THE ENZYME DEFICIENT IN HEREDITARY TYROSINEMIA - ASSIGNMENT OF THE GENE TO CHROMOSOME-15
    PHANEUF, D
    LABELLE, Y
    BERUBE, D
    ARDEN, K
    CAVENEE, W
    GAGNE, R
    TANGUAY, RM
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 48 (03) : 525 - 535
  • [36] Clinical and genetic characteristics of two patients with tyrosinemia type 1 in Slovenia - A novel fumarylacetoacetate hydrolase (FAH) intronic disease-causing variant
    Sikonja, Jaka
    Brecelj, Jernej
    Tansek, Mojca Zerjav
    Lampret, Barbka Repic
    Torkar, Ana Drole
    Klemencic, Simona
    Lipovec, Neza
    Kralj, Valentina Stefanova
    Bertok, Sara
    Kovac, Jernej
    Kotnik, Barbara Faganel
    Tesarova, Marketa
    Remec, Ziga Iztok
    Debeljak, Marusa
    Battelino, Tadej
    Groselj, Urh
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2022, 30
  • [37] The Caenorhabditis elegans K10C2.4 gene encodes a member of the fumarylacetoacetate hydrolase family - A caenorhabditis elegans model of type i tyrosinemia
    Fisher, Alfred L.
    Page, Kathryn E.
    Lithgow, Gordon J.
    Nash, Lindsey
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (14) : 9127 - 9135
  • [38] In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I
    Manning, K
    Al-Dhalimy, M
    Finegold, M
    Grompe, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (21) : 11928 - 11933
  • [39] Geographic and ethnic distribution of mutations in the FAH gene of hereditary tyrosinemia type 1 patients in Europe.
    van Amstel, JKP
    Zewald, RA
    Van den Berg, IET
    Berger, R
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 291 - 291
  • [40] Cytoplasmic nonsense-mediated mRNA decay for a nonsense (W262X) transcript of the gene responsible for hereditary tyrosinemia, fumarylacetoacetate hydrolase
    Dreumont, N
    Maresca, A
    Khandjian, EW
    Baklouti, F
    Tanguay, RM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 324 (01) : 186 - 192
12345